APA ציטוט

Bhatia, S., Pavlick, A. C., Boasberg, P., Thompson, J. A., Mulligan, G., Pickard, M. D., . . . Hamid, O. (2016). A phase I study of the investigational NEDD8-activating enzyme inhibitor pevonedistat (TAK-924/MLN4924) in patients with metastatic melanoma. Invest New Drugs.

Citação norma Chicago

Bhatia, Shailender, Anna C. Pavlick, Peter Boasberg, John A. Thompson, George Mulligan, Michael D. Pickard, Hélène Faessel, Bruce J. Dezube, and Omid Hamid. "A Phase I Study of the Investigational NEDD8-activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients With Metastatic Melanoma." Invest New Drugs 2016.

ציטוט MLA

Bhatia, Shailender, et al. "A Phase I Study of the Investigational NEDD8-activating Enzyme Inhibitor Pevonedistat (TAK-924/MLN4924) in Patients With Metastatic Melanoma." Invest New Drugs 2016.